title: High-dose cyclophosphamide and etoposide for patients with refractory acute myeloid leukemia: a case series.
authors.forename: Jeffrey
authors.initials: J
authors.lastname: Talbot
authors.forename: David A
authors.initials: DA
authors.lastname: Rizzieri
authors.forename: Carlos M
authors.initials: CM
authors.lastname: DeCastro
authors.forename: Joseph O
authors.initials: JO
authors.lastname: Moore
authors.forename: Patrick
authors.initials: P
authors.lastname: Buckley
authors.forename: Rhonda
authors.initials: R
authors.lastname: Laney
authors.forename: Diane
authors.initials: D
authors.lastname: Stevenson
authors.forename: Heather
authors.initials: H
authors.lastname: Brumbaugh
authors.forename: Jon P
authors.initials: JP
authors.lastname: Gockerman
mesh_terms: D000208:Acute Disease; D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage* / Q000633:toxicity; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000633:toxicity; D004341:Drug Evaluation; D005047:Etoposide / Q000008:administration & dosage / Q000633:toxicity; D005260:Female; D006801:Humans; D007951:Leukemia, Myeloid / Q000150:complications / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D016879:Salvage Therapy; D016896:Treatment Outcome
chemical_list: D005047:Etoposide; D003520:Cyclophosphamide